Biologic and Systemic Agents in Dermatology '18
目次
Chapter 1 – Tumor Necrosis Factor Inhibition in the Treatment of Psoriasis and Psoriatic ArthritisChapter 2 – Therapies Targeting Interleukin-23 in Psoriatic DiseaseChapter 3 – Interleukin 17 – Pathogenesis in Psoriatic Disease and Treatment through Selective BlockadeChapter 4 – Conventional Systemic Agents for Psoriatic Disease Chapter 5 – The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic ConditionsChapter 6 – PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin ConditionsChapter 7 – Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic ConditionsChapter 8 – Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic DermatitisChapter 9 – Oral Agents for Atopic DermatitisChapter 10 – Role of Intravenous Immunoglobulin in Dermatologic DisordersChapter 11 – Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic DiseasesChapter 12 – Oral Systemic Agents for Various Immunobullous DisordersChapter 13 – Anti-IgE Therapy in DermatologyChapter 14 - Oral Retinoids in DermatologyChapter 15 – Updates in Immunotherapies for MelanomaChapter 16 – Sonic Hedgehog Inhibition in the Treatment of Advanced BCC
カート
カートに商品は入っていません。